ArriVent BioPharma, Inc. · NASDAQ:AVBP
ArriVent BioPharma, Inc. shareholders
As of Sep 30, 2026, 146 institutions reported holding ArriVent BioPharma, Inc., 97.6% of its shares. Largest: Montanova Capital, LLC, Infinitum Asset Management, LLC and Hhlr Advisors, LTD. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of ArriVent BioPharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Montanova Capital, LLC | 4.93M | 9.5% | +410K | Nov 16, 2026 |
| Infinitum Asset Management, LLC | 4.52M | 8.7% | +85,539 | Nov 16, 2026 |
| Hhlr Advisors, LTD. | 3.93M | 7.6% | no change | Nov 16, 2026 |
| BlackRock | 3.41M | 6.6% | +157K | Nov 13, 2026 |
| Orbimed Advisors LLC | 3.03M | 5.9% | no change | Nov 16, 2026 |
| Fidelity | 2.97M | 5.7% | +188K | Nov 10, 2026 |
| Vanguard | 2.74M | 5.3% | +343K | Nov 13, 2026 |
| Octagon Capital Advisors LP | 2.14M | 4.1% | +170K | Nov 16, 2026 |
| Vivo Capital, LLC | 1.79M | 3.5% | +105K | Nov 13, 2026 |
| State Street | 1.76M | 3.4% | +70,113 | Nov 12, 2026 |